These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 21294502

  • 1. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P, Trakulsomboon S, Dejsirilert S, Thongmali O, Sawanpanyalert P, Aswapokee N, Buppanharun W.
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [Abstract] [Full Text] [Related]

  • 2. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [Abstract] [Full Text] [Related]

  • 3. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S, Ali SZ, Akram M, Ali SM, Khan AU.
    J Trop Pediatr; 2010 Apr 17; 56(2):90-6. PubMed ID: 19608665
    [Abstract] [Full Text] [Related]

  • 5. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 17; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 17; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 7. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 17; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS, Byeon J, Yang J, Yoo JI, Chung GT, Lee YS.
    Diagn Microbiol Infect Dis; 2010 Jul 17; 67(3):261-5. PubMed ID: 20462727
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.
    Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP, Colombian Nosocomial Resistance Study Group (See ).
    Diagn Microbiol Infect Dis; 2004 Jul 17; 49(3):217-22. PubMed ID: 15246513
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut.
    Dandekar PK, Tetreault J, Quinn JP, Nightingale CH, Nicolau DP.
    Diagn Microbiol Infect Dis; 2004 May 17; 49(1):37-9. PubMed ID: 15135498
    [Abstract] [Full Text] [Related]

  • 11. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH.
    J Antimicrob Chemother; 2005 Oct 17; 56(4):698-702. PubMed ID: 16141280
    [Abstract] [Full Text] [Related]

  • 12. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec 17; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 13. Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O, López-Riquelme N, Rodríguez JC, Santibañez M, Alvarez L, Galiana A, Ruiz-García M, López-García P, Royo G.
    Int J Antimicrob Agents; 2012 Aug 17; 40(2):189-90. PubMed ID: 22727771
    [No Abstract] [Full Text] [Related]

  • 14. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Romero L, López L, Rodríguez-Baño J, Ramón Hernández J, Martínez-Martínez L, Pascual A.
    Clin Microbiol Infect; 2005 Aug 17; 11(8):625-31. PubMed ID: 16008614
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F, Ak K, Kucukbasmaci O, Samasti M.
    Chemotherapy; 2009 Aug 17; 55(4):293-7. PubMed ID: 19521075
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.
    Romero ED, Padilla TP, Hernández AH, Grande RP, Vázquez MF, García IG, García-Rodríguez JA, Muñoz Bellido JL.
    Diagn Microbiol Infect Dis; 2007 Dec 17; 59(4):433-7. PubMed ID: 17913435
    [Abstract] [Full Text] [Related]

  • 17. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 17; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 18. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T.
    Nihon Rinsho; 2003 Mar 17; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
    Lee K, Lim JK, Yong D, Yum J, Chong Y, Okamoto R, Inoue M.
    J Clin Microbiol; 2001 Oct 17; 39(10):3696-9. PubMed ID: 11574594
    [Abstract] [Full Text] [Related]

  • 20. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B, Mehta S.
    Indian J Pathol Microbiol; 2005 Jan 17; 48(1):45-8. PubMed ID: 16758790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.